Research on vaccines during pregnancy: Reference values for vital signs and laboratory assessments

Journal Article

The Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, National Institutes of Health organized a series of conferences, "Enrolling Pregnant Women in Clinical Trials of Vaccines and Therapeutics", to discuss enrollment and safety assessments of pregnant women in clinical trials of vaccines. Experts in obstetrics, maternal-fetal medicine, infectious diseases, pediatrics, neonatology, genetics, vaccinology and clinical trial design were charged with identifying normal ranges for vital signs and laboratory assessments in pregnancy. A grading system for adverse events was then developed. © 2013 Elsevier Ltd.

Full Text

Duke Authors

Cited Authors

  • Sheffield, JS; Munoz, FM; Beigi, RH; Rasmussen, SA; Edwards, KM; Read, JS; Heine, RP; Ault, KA; Swamy, GK; Jevaji, I; Spong, CY; Fortner, KB; Patel, SM; Nesin, M

Published Date

  • 2013

Published In

Volume / Issue

  • 31 / 40

Start / End Page

  • 4264 - 4273

International Standard Serial Number (ISSN)

  • 0264-410X

Digital Object Identifier (DOI)

  • 10.1016/j.vaccine.2013.07.031